The GuardianMay 30, 2026, 5:00 PM
1 report1 sourceSimilarity 0.30
Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy Doctors have hailed “unprecedented” trial results that show a triple-action cancer jab can…
The Guardian
The Straits TimesMay 31, 2026, 2:06 PM
1 report1 sourceSimilarity 0.26
Patients on ivonescimab lived longer by four months compared with those on immunotherapy.
The Straits Times
The GuardianMay 31, 2026, 12:00 PM
1 report1 sourceSimilarity 0.26
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial…
The Guardian
The GuardianMay 31, 2026, 2:00 PM
1 report1 sourceSimilarity 0.24
Tribunal orders company to pay Shabin Shaji for care work he was not given after coming to UK, in landmark case An Indian citizen who came to the UK to work as a care worker through the post-Brexit visa scheme has been…
The Guardian
CNBCJun 1, 2026, 5:58 PM
2 reports2 sourcesSimilarity 0.22
The AI-Driven Enterprise Institute released new research that breaks down the degree to which S&P 500 companies are adopting AI compared with their peers. Grouped from 2 articles across 2 sources.
Al Jazeera, CNBC
The Straits TimesMay 31, 2026, 2:34 PM
2 reports2 sourcesSimilarity 0.21
Erleada reduced the risk of the cancer spreading or death by 20 per cent. Grouped from 2 articles across 2 sources.
CNBC, The Straits Times